• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 233/56 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Patent holdings for IPC class C07D 233/56

Total number of patents in this class: 208

10-year publication summary

19
22
23
26
8
10
7
11
4
1
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Gilead Sciences, Inc.
1951
12
BASF SE
20432
8
FUJIFILM Corporation
28805
7
Agency for Science, Technology and Research
3561
5
University of Maryland, Baltimore
1002
5
Bayer Cropscience AG
2138
4
Nippon Soda Co., Ltd.
883
4
sanofi-aventis
393
4
Janssen Pharmaceutica N.V.
3612
3
Alexion Pharmaceuticals, Inc.
622
3
Kureha Corporation
1026
3
NMD Pharma A/S
37
3
Sanofi
3951
3
Novartis AG
11254
2
Centre National de La Recherche Scientifique
10102
2
Murata Manufacturing Co., Ltd.
23702
2
Dow Technology Investments LLC
273
2
PRC-DeSoto International, Inc.
579
2
University of Florida Research Foundation, Inc.
3958
2
BioLab Sanus Farmaceutica Ltda.
51
2
Other owners 130